Fate Therapeutics.jpg
Fate Therapeutics Announces Preclinical Data Highlighting Persistent Effector Function of Allogeneic Natural Killer Cell Cancer Immunotherapy
May 16, 2016 08:01 ET | Fate Therapeutics, Inc.
Adaptive NK Cell Therapy Advancing Toward First-in-Human Clinical Trial in Collaboration with University of Minnesota Program to be Presented Today at Innate Killer Summit 2016 SAN DIEGO, May 16,...
Fate Therapeutics.jpg
Fate Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference
April 05, 2016 16:01 ET | Fate Therapeutics, Inc.
SAN DIEGO, April 05, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer...
WhiteWave Foods to P
WhiteWave Foods to Present at the Consumer Analyst Group of New York Conference
February 04, 2016 16:20 ET | WhiteWave Foods
DENVER, Feb. 04, 2016 (GLOBE NEWSWIRE) -- The WhiteWave Foods Company (NYSE:WWAV) today announced that WhiteWave management will present to the investment community at the Consumer Analyst...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Selected to Present at Biotech Showcase™ 2016
January 08, 2016 09:00 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group to Present Phase IIa Results from CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced Diffuse Large B Cell Lymphoma
October 23, 2015 08:15 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Oct. 23, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of...
Sucampo Announces We
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference
July 01, 2015 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 1, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces We
Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference
February 22, 2015 14:30 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
AIMLogo.jpg
Hemispherx Biopharma, Inc. to Present Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference
March 19, 2014 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, March 19, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) will participate in the 11th Biennial International Research and Clinical Conference to be held in San...
Beamz Interactive Inc. Announces Availability of New Online Investor Presentation
September 23, 2013 07:31 ET | Beamz Interactive, Inc.
SCOTTSDALE, AZ--(Marketwired - Sep 23, 2013) - Beamz Interactive, Inc. (OTCQB: BZIC), an emerging growth technology company specializing in state-of-the-art interactive music products, today...
Communications Coach and Bestselling Author, Carmine Gallo Announces the Launch of the Carmine Gallo Academy
January 16, 2013 08:11 ET | GALLO COMMUNICATIONS GROUP
PLEASANTON, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) -- Communications Coach Carmine Gallo brings his popular in-person trainings to the eLearning space with the launch of the Carmine Gallo Academy. The...